178 related articles for article (PubMed ID: 21228771)
41. Phenotypic and immunoregulatory analysis of intestinal T-cells in patients with inflammatory bowel disease: evaluation of an in vitro model.
Niessner M; Volk BA
Eur J Clin Invest; 1995 Mar; 25(3):155-64. PubMed ID: 7781661
[TBL] [Abstract][Full Text] [Related]
42. Over-expression of forkhead box P3 and its association with receptor activator of nuclear factor-kappa B ligand, interleukin (IL) -17, IL-10 and transforming growth factor-beta during the progression of chronic periodontitis.
Dutzan N; Gamonal J; Silva A; Sanz M; Vernal R
J Clin Periodontol; 2009 May; 36(5):396-403. PubMed ID: 19419438
[TBL] [Abstract][Full Text] [Related]
43. Preferential activation of CD4+V beta 5.2/5.3+ intestinal intraepithelial lymphocytes in the inflamed lesions of Crohn's disease.
Watanabe M; Hayashi A; Hosoda Y; Ohara M; Iwao Y; Ishii H; Ishikawa H; Nanno M; Hibi T
Clin Immunol Immunopathol; 1996 Feb; 78(2):130-9. PubMed ID: 8625555
[TBL] [Abstract][Full Text] [Related]
44. Hepatitis C virus-specific Th17 cells are suppressed by virus-induced TGF-beta.
Rowan AG; Fletcher JM; Ryan EJ; Moran B; Hegarty JE; O'Farrelly C; Mills KH
J Immunol; 2008 Oct; 181(7):4485-94. PubMed ID: 18802051
[TBL] [Abstract][Full Text] [Related]
45. Mucosal IL-8 and TGF-beta recruit blood monocytes: evidence for cross-talk between the lamina propria stroma and myeloid cells.
Smythies LE; Maheshwari A; Clements R; Eckhoff D; Novak L; Vu HL; Mosteller-Barnum LM; Sellers M; Smith PD
J Leukoc Biol; 2006 Sep; 80(3):492-9. PubMed ID: 16793909
[TBL] [Abstract][Full Text] [Related]
46. Interleukin-18 and Crohn's disease.
Kanai T; Watanabe M; Okazawa A; Sato T; Hibi T
Digestion; 2001; 63 Suppl 1():37-42. PubMed ID: 11173908
[TBL] [Abstract][Full Text] [Related]
47. Cytokine network in rectal mucosa in perianal Crohn's disease: relations with inflammatory parameters and need for surgery.
Ruffolo C; Scarpa M; Faggian D; Pozza A; Navaglia F; D'Incà R; Hoxha P; Romanato G; Polese L; Sturniolo GC; Plebani M; D'Amico DF; Angriman I
Inflamm Bowel Dis; 2008 Oct; 14(10):1406-12. PubMed ID: 18452203
[TBL] [Abstract][Full Text] [Related]
48. Transforming growth factor and intestinal inflammation: the role of nutrition.
Ruemmele FM; Garnier-Lengliné H
Nestle Nutr Inst Workshop Ser; 2013; 77():91-8. PubMed ID: 24107499
[TBL] [Abstract][Full Text] [Related]
49. Differential regulation of interleukin 17 and interferon gamma production in inflammatory bowel disease.
Rovedatti L; Kudo T; Biancheri P; Sarra M; Knowles CH; Rampton DS; Corazza GR; Monteleone G; Di Sabatino A; Macdonald TT
Gut; 2009 Dec; 58(12):1629-36. PubMed ID: 19740775
[TBL] [Abstract][Full Text] [Related]
50. Role of the IL-23/IL-17 axis in Crohn's disease.
Siakavellas SI; Bamias G
Discov Med; 2012 Oct; 14(77):253-62. PubMed ID: 23114581
[TBL] [Abstract][Full Text] [Related]
51. Transforming growth factor β signaling controls activities of human intestinal CD8(+)T suppressor cells.
Rabinowitz KM; Wang Y; Chen EY; Hovhannisyan Z; Chiang D; Berin MC; Dahan S; Chaussabel D; Ma'ayan A; Mayer L
Gastroenterology; 2013 Mar; 144(3):601-612.e1. PubMed ID: 23232296
[TBL] [Abstract][Full Text] [Related]
52. Expansion of IL-23 receptor bearing TNFR2+ T cells is associated with molecular resistance to anti-TNF therapy in Crohn's disease.
Schmitt H; Billmeier U; Dieterich W; Rath T; Sonnewald S; Reid S; Hirschmann S; Hildner K; Waldner MJ; Mudter J; Hartmann A; Grützmann R; Neufert C; Münster T; Neurath MF; Atreya R
Gut; 2019 May; 68(5):814-828. PubMed ID: 29848778
[TBL] [Abstract][Full Text] [Related]
53. Regulation of human lymphocyte IL-4 secretion by intestinal epithelial cell-derived interleukin-7 and transforming growth factor-beta.
Jiang Y; McGee DW
Clin Immunol Immunopathol; 1998 Sep; 88(3):287-96. PubMed ID: 9743616
[TBL] [Abstract][Full Text] [Related]
54. Intestinal IFN-γ-producing type 1 regulatory T cells coexpress CCR5 and programmed cell death protein 1 and downregulate IL-10 in the inflamed guts of patients with inflammatory bowel disease.
Alfen JS; Larghi P; Facciotti F; Gagliani N; Bosotti R; Paroni M; Maglie S; Gruarin P; Vasco CM; Ranzani V; Frusteri C; Iseppon A; Moro M; Crosti MC; Gatti S; Pagani M; Caprioli F; Abrignani S; Flavell RA; Geginat J
J Allergy Clin Immunol; 2018 Nov; 142(5):1537-1547.e8. PubMed ID: 29369775
[TBL] [Abstract][Full Text] [Related]
55. Involvement of interleukin 18 in Crohn's disease: evidence from in vitro analysis of human gut inflammatory cells and from experimental colitis models.
Maerten P; Shen C; Colpaert S; Liu Z; Bullens DA; van Assche G; Penninckx F; Geboes K; Vanham G; Rutgeerts P; Ceuppens JL
Clin Exp Immunol; 2004 Feb; 135(2):310-7. PubMed ID: 14738461
[TBL] [Abstract][Full Text] [Related]
56. A major population of mucosal memory CD4+ T cells, coexpressing IL-18Rα and DR3, display innate lymphocyte functionality.
Holmkvist P; Roepstorff K; Uronen-Hansson H; Sandén C; Gudjonsson S; Patschan O; Grip O; Marsal J; Schmidtchen A; Hornum L; Erjefält JS; Håkansson K; Agace WW
Mucosal Immunol; 2015 May; 8(3):545-58. PubMed ID: 25269704
[TBL] [Abstract][Full Text] [Related]
57. Th1-mediated intestinal inflammation in Crohn's disease may be induced by activation of lamina propria lymphocytes through synergistic stimulation of interleukin-12 and interleukin-18 without T cell receptor engagement.
Okazawa A; Kanai T; Watanabe M; Yamazaki M; Inoue N; Ikeda M; Kurimoto M; Ishii H; Hibi T
Am J Gastroenterol; 2002 Dec; 97(12):3108-17. PubMed ID: 12492197
[TBL] [Abstract][Full Text] [Related]
58. Lamina Propria CD4+LAP+ Regulatory T Cells Are Increased in Active Ulcerative Colitis but Show Increased IL-17 Expression and Reduced Suppressor Activity.
D'Ambrosio A; Cossu A; Amendola A; Zandri A; Butera A; Sanchez M; Biffoni M; Pronio A; Montesani C; Kohn A; Pica R; Boirivant M
J Crohns Colitis; 2016 Mar; 10(3):346-53. PubMed ID: 26589955
[TBL] [Abstract][Full Text] [Related]
59. Massive interleukin-12-induced interferon-gamma production by interleukin-15-stimulated lamina propria lymphocytes followed by down-regulation of the interleukin-12 receptor.
Ebert EC; Jabri B
Immunology; 2008 Aug; 124(4):453-60. PubMed ID: 18540964
[TBL] [Abstract][Full Text] [Related]
60. Interleukin-25 inhibits interleukin-12 production and Th1 cell-driven inflammation in the gut.
Caruso R; Sarra M; Stolfi C; Rizzo A; Fina D; Fantini MC; Pallone F; MacDonald TT; Monteleone G
Gastroenterology; 2009 Jun; 136(7):2270-9. PubMed ID: 19505427
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
